Daniel Bergsagel MD
- Department of Pediatrics
Associate Professor
-
Children's Medical Office Building at Scottish Rite Hospital
Aflac Cancer and Blood Disorders Center
5461 Meridian Mark Road
Academic Appointment
- Associate Professor of Pediatrics, Emory University
Education
Degrees
- MD from Queen’s University
- BS from Trinity College, University of Toronto
Research
Focus
- Clinical research protocols in childhood leukemia and lymphoma
Publications
-
A single-center retrospective review of pediatric cases of progressive transformation of germinal centers.
Pediatr Blood Cancer Volume: 70 Page(s): e30283
06/01/2023 Authors: Sadanand A; Aljudi A; Bergsagel DJ; Keller FG -
The American Society of Pediatric Hematology Oncology workforce, productivity, and fellowship assessment: Current state of the workforce.
Pediatr Blood Cancer Volume: 70 Page(s): e30221
05/01/2023 Authors: Hastings C; Borinstein SC; Bergsagel DJ; Hagstrom JN; Hooker R; Nugent DJ; Hudspeth M; American Society of Pediatric Hematology Oncology Workforce Publication Workgroup -
Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components.
Cancer Rep (Hoboken) Volume: 6 Page(s): e1665
01/01/2023 Authors: Stevenson J; DeGroote NP; Keller F; Brock KE; Bergsagel DJ; Miller TP; Cornwell P; Fasano R; Chonat S; Castellino SM -
CHARACTERISTICS AND OUTCOMES OF PEDIATRIC ONCOLOGY PATIENTS AT RISK FOR TRANSFUSION REFUSAL
Volume: 68 Page(s): S97 - S98
06/01/2021 Authors: Stevenson J; DeGroote N; Choudhury T; Keller F; Brock K; Bergsagel DJ; Miller T; Cornwell P; Chonat S; Castellino S -
Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias.
BMC Cancer Volume: 21 Page(s): 474
04/29/2021 Authors: Smith SM; Sabnis HS; Lewis RW; Effinger KE; Bergsagel J; Patterson B; Mertens A; Sakamoto KM; Schapira L; Castellino SM -
Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia.
Hemasphere Volume: 4 Page(s): e486
12/01/2020 Authors: Jain J; Weinzierl EP; Saxe D; Bergsagel J; Gotlib J; Reiter A; Raikar SS -
Screening practices for late effects in pediatric patients on tyrosine kinase inhibitors.
Volume: 38
05/20/2020 Authors: Smith SM; Sabnis HS; Lewis RW; Effinger KE; Bergsagel DJ; Patterson B; Mertens AC; Sakamoto K; Schapira L; Castellino SM -
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group.
Pediatr Blood Cancer Volume: 66 Page(s): e27827
09/01/2019 Authors: Athale U; Hijiya N; Patterson BC; Bergsagel J; Andolina JR; Bittencourt H; Schultz KR; Burke MJ; Redell MS; Kolb EA -
Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for Chronic Myeloid Leukaemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia.
Br J Haematol Volume: 185 Page(s): 795 - 799
05/01/2019 Authors: Sabnis HS; Keenum C; Lewis RW; Patterson B; Bergsagel J; Effinger KE; Silverman E; Mertens AC; Castellino SM -
ALLOPURINOL USE WITH 6-MERCAPTOPURINE IN MAINTENANCE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
PEDIATRIC BLOOD & CANCER Volume: 65
06/01/2018 Authors: Phillips L; Minson K; Castellino S; Bergsagel J; Lew G; Sabnis H; Pauly M; Keller F